Europe Veterinary Vaccines Market Size and Forecast (2021 - 2031)
The Europe Veterinary Vaccines Market is projected to grow significantly, reaching an estimated US$ 4,051.7 million by 2031, up from US$ 2,850.7 million in 2024. This growth represents a compound annual growth rate (CAGR) of 5.2% from 2025 to 2031.
Executive Summary and Market Analysis
The veterinary vaccines market in Europe encompasses several key countries, including France, Germany, the UK, Italy, Greece, Spain, and others. Europe plays a crucial role in the global veterinary vaccines market, supported by a well-established veterinary public health system and the presence of major industry players. The market's growth is primarily driven by advancements in research and development aimed at enhancing veterinary vaccine technology and improving disease prevention in animals. The increasing number of veterinary diagnostic laboratories across Europe has bolstered disease detection capabilities, thereby heightening the demand for effective vaccination programs.
Additionally, the rising incidence of zoonotic diseases and a growing emphasis on animal health to ensure food safety are significant factors propelling market growth. Continued support from government and regulatory bodies for vaccination initiatives and animal welfare in various European nations further strengthens the market's position. These elements collectively contribute to Europe’s ongoing role in the development and innovation of the global veterinary vaccines sector.
Strategic Insights
Market Segmentation Analysis
The Europe Veterinary Vaccines Market can be segmented based on several criteria:
Over the last decade, there has been a notable shift in public perception regarding animal health, recognizing it as essential for animal welfare, public health, food security, and economic stability. The Food and Agriculture Organization (FAO) emphasizes that healthy livestock are vital for sustainable food systems, which drives the adoption of vaccines to prevent diseases such as foot-and-mouth disease, brucellosis, and avian influenza. Concurrently, pet owners are becoming increasingly aware of the importance of preventive healthcare, including vaccinations, to ensure their companion animals lead longer, healthier lives.
The availability of information on animal health through digital platforms, veterinary organizations, and public awareness campaigns has empowered both pet owners and farmers to understand the risks associated with preventable diseases, including zoonotic diseases like rabies and leptospirosis. Global organizations such as the WHO and the World Organization for Animal Health (WOAH) have initiated campaigns to raise awareness about the critical role of vaccination in controlling zoonotic diseases. The WHO's Global Strategic Plan aims to eliminate human deaths from dog-mediated rabies by 2030, promoting large-scale vaccine adoption.
Veterinarians are also pivotal in advocating for preventive care, educating pet owners and livestock farmers about vaccination schedules, the benefits of immunization, and the risks of neglecting preventive measures. Innovations in veterinary medicine, such as combination vaccines that simplify administration and enhance compliance, further contribute to this growing awareness.
As a result, the increasing recognition of animal health's importance has significantly driven the growth of the veterinary vaccines market. With collaborative efforts from governments, veterinarians, and global organizations to emphasize preventive care, the adoption of vaccines for both companion animals and livestock is on the rise. This trend is expected to persist as more individuals acknowledge the interconnectedness of animal health, human health, and economic stability.
Country Insights
The Europe Veterinary Vaccines Market is also analyzed by country, with key players including the United Kingdom, Germany, France, Italy, Spain, and others. Germany, in particular, held the largest market share in 2024.
Germany is a leading agricultural producer in Europe, with a robust livestock sector known for its pork, beef, and poultry production. The health of livestock is crucial for maintaining agricultural output and meeting stringent health standards for export markets. Vaccines play a vital role in ensuring livestock health, preventing outbreaks, and minimizing production losses. As consumers become more conscious of food origins and quality, there is a growing demand for high-quality, disease-free meat and dairy products. Consequently, German farmers are increasingly adopting vaccination programs to ensure their animals remain healthy and compliant with both domestic and international standards.
Thus, the rising demand for safe and high-quality animal-derived food is significantly boosting the need for veterinary vaccines in Germany.
Company Profiles
Key players in the Europe Veterinary Vaccines Market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.
Executive Summary and Market Analysis
The veterinary vaccines market in Europe encompasses several key countries, including France, Germany, the UK, Italy, Greece, Spain, and others. Europe plays a crucial role in the global veterinary vaccines market, supported by a well-established veterinary public health system and the presence of major industry players. The market's growth is primarily driven by advancements in research and development aimed at enhancing veterinary vaccine technology and improving disease prevention in animals. The increasing number of veterinary diagnostic laboratories across Europe has bolstered disease detection capabilities, thereby heightening the demand for effective vaccination programs.
Additionally, the rising incidence of zoonotic diseases and a growing emphasis on animal health to ensure food safety are significant factors propelling market growth. Continued support from government and regulatory bodies for vaccination initiatives and animal welfare in various European nations further strengthens the market's position. These elements collectively contribute to Europe’s ongoing role in the development and innovation of the global veterinary vaccines sector.
Strategic Insights
Market Segmentation Analysis
The Europe Veterinary Vaccines Market can be segmented based on several criteria:
- By Technology: The market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. In 2024, Live Attenuated Vaccines held the largest market share.
- By Animal Type: The market is categorized into Companion Animals and Livestock & Poultry, with Livestock and Poultry dominating the market in 2024.
- By Companion Animal: This segment includes Dogs, Cats, Horses, and Others, where Dogs represented the largest share in 2024.
- By Livestock and Poultry: This includes Chicken, Cattle, and Others, with Chicken leading the market share in 2024.
- By Route of Administration: The market is segmented into Intramuscular, Subcutaneous, and Others, with Intramuscular administration being the most prevalent in 2024.
- By End User: This includes Veterinary Hospitals, Veterinary Clinics, and Others, where Veterinary Hospitals held the largest share in 2024.
Over the last decade, there has been a notable shift in public perception regarding animal health, recognizing it as essential for animal welfare, public health, food security, and economic stability. The Food and Agriculture Organization (FAO) emphasizes that healthy livestock are vital for sustainable food systems, which drives the adoption of vaccines to prevent diseases such as foot-and-mouth disease, brucellosis, and avian influenza. Concurrently, pet owners are becoming increasingly aware of the importance of preventive healthcare, including vaccinations, to ensure their companion animals lead longer, healthier lives.
The availability of information on animal health through digital platforms, veterinary organizations, and public awareness campaigns has empowered both pet owners and farmers to understand the risks associated with preventable diseases, including zoonotic diseases like rabies and leptospirosis. Global organizations such as the WHO and the World Organization for Animal Health (WOAH) have initiated campaigns to raise awareness about the critical role of vaccination in controlling zoonotic diseases. The WHO's Global Strategic Plan aims to eliminate human deaths from dog-mediated rabies by 2030, promoting large-scale vaccine adoption.
Veterinarians are also pivotal in advocating for preventive care, educating pet owners and livestock farmers about vaccination schedules, the benefits of immunization, and the risks of neglecting preventive measures. Innovations in veterinary medicine, such as combination vaccines that simplify administration and enhance compliance, further contribute to this growing awareness.
As a result, the increasing recognition of animal health's importance has significantly driven the growth of the veterinary vaccines market. With collaborative efforts from governments, veterinarians, and global organizations to emphasize preventive care, the adoption of vaccines for both companion animals and livestock is on the rise. This trend is expected to persist as more individuals acknowledge the interconnectedness of animal health, human health, and economic stability.
Country Insights
The Europe Veterinary Vaccines Market is also analyzed by country, with key players including the United Kingdom, Germany, France, Italy, Spain, and others. Germany, in particular, held the largest market share in 2024.
Germany is a leading agricultural producer in Europe, with a robust livestock sector known for its pork, beef, and poultry production. The health of livestock is crucial for maintaining agricultural output and meeting stringent health standards for export markets. Vaccines play a vital role in ensuring livestock health, preventing outbreaks, and minimizing production losses. As consumers become more conscious of food origins and quality, there is a growing demand for high-quality, disease-free meat and dairy products. Consequently, German farmers are increasingly adopting vaccination programs to ensure their animals remain healthy and compliant with both domestic and international standards.
Thus, the rising demand for safe and high-quality animal-derived food is significantly boosting the need for veterinary vaccines in Germany.
Company Profiles
Key players in the Europe Veterinary Vaccines Market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. EUROPE VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VETERINARY VACCINES MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Veterinary Vaccines Market Forecast and Analysis
7. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY TECHNOLOGY
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ANIMAL TYPE
8.1 Companion
8.1.1 Overview
8.1.2 Companion: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY COMPANION
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY LIVESTOCK AND POULTRY
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY END USER
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. EUROPE VETERINARY VACCINES MARKET - COUNTRY ANALYSIS
13.1 Europe
13.1.1 Europe Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 Europe Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 United Kingdom: Europe Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 United Kingdom: Europe Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 United Kingdom: Europe Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 United Kingdom: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 United Kingdom: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 United Kingdom: Europe Veterinary Vaccines Market Share - by End User
13.2.3.3 Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Germany: Europe Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Germany: Europe Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Germany: Europe Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Germany: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Germany: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Germany: Europe Veterinary Vaccines Market Share - by End User
13.3.4.4 France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 France: Europe Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 France: Europe Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 France: Europe Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 France: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 France: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 France: Europe Veterinary Vaccines Market Share - by End User
13.4.5.5 Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4.5.5.1 Italy: Europe Veterinary Vaccines Market Share - by Technology
13.4.5.5.2 Italy: Europe Veterinary Vaccines Market Share - by Animal Type
13.4.5.5.3 Italy: Europe Veterinary Vaccines Market Share - by Companion
13.4.5.5.4 Italy: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.4.5.5.5 Italy: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.4.5.5.6 Italy: Europe Veterinary Vaccines Market Share - by End User
13.5.6.6 Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.5.6.6.1 Spain: Europe Veterinary Vaccines Market Share - by Technology
13.5.6.6.2 Spain: Europe Veterinary Vaccines Market Share - by Animal Type
13.5.6.6.3 Spain: Europe Veterinary Vaccines Market Share - by Companion
13.5.6.6.4 Spain: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.5.6.6.5 Spain: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.5.6.6.6 Spain: Europe Veterinary Vaccines Market Share - by End User
13.6.7.7 Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.6.7.7.1 Rest of Europe: Europe Veterinary Vaccines Market Share - by Technology
13.6.7.7.2 Rest of Europe: Europe Veterinary Vaccines Market Share - by Animal Type
13.6.7.7.3 Rest of Europe: Europe Veterinary Vaccines Market Share - by Companion
13.6.7.7.4 Rest of Europe: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.6.7.7.5 Rest of Europe: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.6.7.7.6 Rest of Europe: Europe Veterinary Vaccines Market Share - by End User
15 INDUSTRY LANDSCAPE
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sant? Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. EUROPE VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VETERINARY VACCINES MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Veterinary Vaccines Market Forecast and Analysis
7. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY TECHNOLOGY
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ANIMAL TYPE
8.1 Companion
8.1.1 Overview
8.1.2 Companion: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY COMPANION
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY LIVESTOCK AND POULTRY
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. EUROPE VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY END USER
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. EUROPE VETERINARY VACCINES MARKET - COUNTRY ANALYSIS
13.1 Europe
13.1.1 Europe Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 Europe Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 United Kingdom: Europe Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 United Kingdom: Europe Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 United Kingdom: Europe Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 United Kingdom: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 United Kingdom: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 United Kingdom: Europe Veterinary Vaccines Market Share - by End User
13.2.3.3 Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Germany: Europe Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Germany: Europe Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Germany: Europe Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Germany: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Germany: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Germany: Europe Veterinary Vaccines Market Share - by End User
13.3.4.4 France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 France: Europe Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 France: Europe Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 France: Europe Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 France: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 France: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 France: Europe Veterinary Vaccines Market Share - by End User
13.4.5.5 Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4.5.5.1 Italy: Europe Veterinary Vaccines Market Share - by Technology
13.4.5.5.2 Italy: Europe Veterinary Vaccines Market Share - by Animal Type
13.4.5.5.3 Italy: Europe Veterinary Vaccines Market Share - by Companion
13.4.5.5.4 Italy: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.4.5.5.5 Italy: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.4.5.5.6 Italy: Europe Veterinary Vaccines Market Share - by End User
13.5.6.6 Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.5.6.6.1 Spain: Europe Veterinary Vaccines Market Share - by Technology
13.5.6.6.2 Spain: Europe Veterinary Vaccines Market Share - by Animal Type
13.5.6.6.3 Spain: Europe Veterinary Vaccines Market Share - by Companion
13.5.6.6.4 Spain: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.5.6.6.5 Spain: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.5.6.6.6 Spain: Europe Veterinary Vaccines Market Share - by End User
13.6.7.7 Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.6.7.7.1 Rest of Europe: Europe Veterinary Vaccines Market Share - by Technology
13.6.7.7.2 Rest of Europe: Europe Veterinary Vaccines Market Share - by Animal Type
13.6.7.7.3 Rest of Europe: Europe Veterinary Vaccines Market Share - by Companion
13.6.7.7.4 Rest of Europe: Europe Veterinary Vaccines Market Share - by Livestock And Poultry
13.6.7.7.5 Rest of Europe: Europe Veterinary Vaccines Market Share - by Route Of Administration
13.6.7.7.6 Rest of Europe: Europe Veterinary Vaccines Market Share - by End User
15 INDUSTRY LANDSCAPE
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sant? Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Veterinary Vaccines Market Segmentation
Table 3. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 30. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 31. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 32. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 33. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 34. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 35. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 36. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 37. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 38. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 39. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 40. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 41. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 42. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 43. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 44. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 45. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 46. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 1. Europe Veterinary Vaccines Market Segmentation
Table 3. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 30. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 31. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 32. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 33. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 34. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 35. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 36. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 37. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 38. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 39. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 40. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 41. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 42. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 43. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 44. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 45. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 46. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. Europe Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Europe Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Europe Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Europe Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Europe Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Europe Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Europe Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Europe Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Europe Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Europe Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Europe Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Europe Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Europe Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Europe Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Europe Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Europe Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. United Kingdom: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Germany: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. France: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Italy: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Spain: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Rest of Europe: Europe Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
